Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03982316 · ClinicalTrials.gov registry record · NA

Telehealth Behavioral Migraine Management

A NA study, sponsored by Albert Einstein College of Medicine.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT03982316: Completed NA study, sponsored by Albert Einstein College of Medicine.

NCT03982316 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03982316, a NA study, has completed, sponsored by Albert Einstein College of Medicine.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This project aims to develop the protocol and obtain feasibility and acceptability information for Telehealth Behavioral Migraine Management in a single-arm pre-post pilot study. The investigator and study team aim to recruit 20 people with migraine from the Montefiore Headache Center in the Bronx New York. Participants will receive the 12-week protocol including a mobile app headache diary, an online patient manual with interactive vignettes, 4 50-minute telehealth sessions, and 3 15-minute check-ins.

Primary Outcome

Feasibility of the study will be based on patient adherence to the protocol. The number of treatment components participants complete (out of 20) will be tabulated. It is hypothesized that at least half of the participants will attend all four study sessions and complete all three self-guided modules. Dropouts will be included in the analysis. Results will be summarized using basic descriptive statistics.

Interventions

  • BEHAVIORAL Telehealth Behavioral Migraine Management
  • BEHAVIORAL Education Modules

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2020-09-15
Est. Completion 2024-10-30
Phase NA
Albert Einstein College of Medicine

175 total trials

What the finished NCT03982316 record still lists

NCT03982316 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Telehealth Behavioral Migraine Management is the first listed.

NCT03982316 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03982316 about?

NCT03982316 is a clinical study titled "Telehealth Behavioral Migraine Management". This project aims to develop the protocol and obtain feasibility and acceptability information for Telehealth Behavioral Migraine Management in a single-arm pre-post pilot study. The investigator and study team aim to recruit 20 people with migraine from the Montefiore Headache Center in the Bronx N...

What is the current status of trial NCT03982316?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-09-15. Estimated completion is 2024-10-30.

What interventions are being tested in trial NCT03982316?

The interventions under investigation include: Telehealth Behavioral Migraine Management (BEHAVIORAL), Education Modules (BEHAVIORAL).

Who is sponsoring clinical trial NCT03982316?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03982316's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03982316, the US trial registry maintained by the National Library of Medicine. NCT03982316 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.